# Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer

> **NCT02705612** · PHASE2 · UNKNOWN · sponsor: **Air Force Military Medical University, China** · enrollment: 60 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** External Beam Radiation Therapy
- **RADIATION:** Internal Radiation Therapy
- **DRUG:** nimotuzumab

## Key facts

- **NCT ID:** NCT02705612
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2016-09
- **Final completion:** 2018-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02705612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02705612, "Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02705612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*